Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Control Sample Storage and Testing – V 2.0

Posted on By

API Manufacturing: SOP for Control Sample Storage and Testing – V 2.0

Standard Operating Procedure for Control Sample Storage and Testing in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/150/2025
Supersedes SOP/API/150/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for proper collection, storage, handling, and periodic testing of control samples of raw materials, intermediates, and APIs in accordance with GMP requirements.

2. Scope

This SOP applies to all control samples retained for quality assessment and stability monitoring of batches manufactured in the API manufacturing unit. It includes retention period, testing frequency, and disposal.

3. Responsibilities

  • QC Analyst: Collect and label control samples properly, record storage location, and conduct periodic testing.
  • QC Reviewer: Review control sample records and confirm adherence to retention and testing schedule.
  • QA Officer: Ensure control samples are handled as per SOP and available for investigation or inspection.
See also  API Manufacturing: SOP for Labeling of Recovered Solvents with Batch Information - V 2.0

4. Accountability

The QC Head is accountable for the integrity, compliance, and traceability of all control samples retained in the facility.

5. Procedure

5.1 Collection of Control Samples

  1. After completion of testing and approval of a batch, collect a sufficient quantity of each sample:
    • Raw materials: 100 g or as per material characteristics
    • API/intermediates: Minimum 2x the quantity required for complete testing
  2. Use clean, inert, leak-proof containers labeled with:
    • Product name and code
    • Batch number
    • Date of manufacture
    • Storage conditions
    • Signature of person collecting
  3. Record entries in the Control Sample Collection Log (Annexure-1).

5.2 Storage Conditions

  1. Store control samples in dedicated cabinets or chambers with environmental monitoring.
  2. Maintain temperature and humidity conditions as specified in the master specification file:
    • Room temperature: 25°C ± 2°C / 60% RH ± 5%
    • Refrigerated storage (if required): 2–8°C
  3. Log storage location in the Control Sample Register (Annexure-2).

5.3 Testing of Control Samples

  1. Perform testing annually or as per defined stability schedule.
  2. Tests to include:
    • Appearance
    • Assay
    • Impurities/Degradation Products
    • Moisture Content
    • Any product-specific critical attributes
  3. Document results in the Control Sample Testing Log (Annexure-3).
  4. If any deterioration is found, initiate investigation and notify QA.
See also  API Manufacturing: SOP for Cleaning of Manufacturing Equipment - V 2.0

5.4 Retention Period

  1. Retain control samples for:
    • 3 years post-manufacture or 1 year after expiry, whichever is later
    • For registered products: as per regulatory requirement
  2. Maintain samples in an orderly manner for easy retrieval during inspections or investigations.

5.5 Disposal of Control Samples

  1. At the end of the retention period, QA to authorize disposal.
  2. Record disposal details in the Disposal Log (Annexure-4).
  3. Ensure destruction is done in line with environmental and EHS policies.

5.6 Inspections and Audits

  1. Control samples should be readily available for:
    • Regulatory inspections
    • Internal QA audits
    • Batch failure investigations
  2. Maintain traceability from batch record to control sample log.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • QC: Quality Control
  • QA: Quality Assurance
  • RH: Relative Humidity
  • SOP: Standard Operating Procedure

7. Documents

  1. Control Sample Collection Log (Annexure-1)
  2. Control Sample Register (Annexure-2)
  3. Control Sample Testing Log (Annexure-3)
  4. Control Sample Disposal Log (Annexure-4)
See also  API Manufacturing: SOP for Operator Training on Solvent Safety - V 2.0

8. References

  • ICH Q1A(R2) – Stability Testing of New Drug Substances
  • 21 CFR 211.170 – Reserve Samples
  • WHO TRS 1010 – Annex 2

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Control Sample Collection Log

Date Batch No. Product Qty Container No. Analyst
13/04/2025 API-B150 Metronidazole 200g CN-27 Sunita Reddy

Annexure-2: Control Sample Register

Sample Code Batch No. Location Storage Condition Remarks
CS-MTZ-150 API-B150 Shelf 3-A 25°C / 60% RH None

Annexure-3: Control Sample Testing Log

Date Batch No. Test Performed Result Remarks
12/04/2025 API-B150 Assay 98.7% Complies

Annexure-4: Control Sample Disposal Log

Date Batch No. Disposal Approved By Method Remarks
13/04/2028 API-B150 QA Officer Incineration Retention expired

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New product line QA Head
13/04/2025 2.0 Added disposal procedure and log format Audit Requirement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Thermal Stability Analysis using GC – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Labeling of Dispensed Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version